Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis

R Dolatkhah, MH Somi, IA Kermani, M Ghojazadeh… - BMC public health, 2015 - Springer
Background Colorectal cancer is the third most common cancer in Iran. The increasing trend
of colorectal cancer incidence in Iran and the close relationship with the geographical …

An epidemiological review of common cancers in Iran; a review article

M Danaei, A Haghdoost, M Momeni - Iranian Journal of Blood and Cancer, 2019 - ijbc.ir
Cancer is a critical health threat in the world. It has an ongoing increasing trend. The aim of
this study was to describe the trend, most common types of cancer and the gender ratio of …

Caring ability and its related factors in the family caregivers of patients with cancer

M Rassouli, S Beiranvand, M Karami… - … Journal of Palliative …, 2023 - magonlinelibrary.com
Background: Caregivers of cancer patients experience a variety of challenges caused by the
prolonged burden of care. Many of these caregivers do not have the necessary knowledge …

Barriers to Applying Integrative Oncology from the Perspective of the Care Providers in Iran: A Mixed-Methods Study

AS Farahani, H Ashrafizadeh, TASK Khoshnazar… - Seminars in Oncology …, 2023 - Elsevier
Objective The present study aims to explain and determine the use of integrative oncology
from the perspective of the care providers in Iran. Data Sources This mixed-methods study is …

[PDF][PDF] Demographic and Socio-Cultural Determinants of Intended and Unintended Pregnancies Among Women Under Cancer Treatment in Sistan and Baluchestan …

K Asadisarvestani, M Navaee - Shiraz E-Medical Journal, 2021 - brieflands.com
Background: One of the main concerns during cancer treatment is the occurrence of
pregnancy due to its wide range of complications. Objectives: This study aimed to determine …

[PDF][PDF] Iranian Journal of Blood & Cancer

H Karami, M Ghasemi, SA Mousavi, M Naderisorki - Ann Oncol, 2005 - ijbc.ir
IRANIAN JOURNAL OF BLOOD AND CANCER 142 decades. 1, 2, 4 Sirolimus is a specific
mammalian target of rapamycin (mTOR) inhibitor which acts as inhibitor of some cellular …